-

- (-%)

X4 Pharmaceuticals, Inc [XFORW]

Source: 

Company Overview

We are late-stage clinical biopharmaceutical company focused on the research, development and commercialization of novel therapeutics for the treatment of rare diseases, with an initial focus on the treatment of people with immune system dysfunction. Our lead product candidate, mavorixafor, is a first-in-class, small molecule inhibitor of the chemokine receptor CXCR4 and is being developed as a once-daily oral therapy.

CountryUS
Headquartersbostonmassachusetts
Phone Number(857) 529-8300
Industrybiological products (no diagnostic substances)
CEOPaula Ragan
Websitehttp://www.x4pharma.com.

Recent Stories